Did Novo Nordisk executive faint in Oval Office? Company clarifies amid buzz about Gordon Findlay

Incident in the Oval Office During Press Conference

During a Thursday press conference in the Oval Office, a man suddenly fainted while President Donald Trump was announcing a deal with drugmakers aimed at lowering the cost of obesity medications. A widely shared video shows the man collapsing, prompting immediate concern and action.

Public Reaction and Initial Identification

Independent journalist Eric Daugherty shared the video online, commenting,

“A man just passed out during President Trump’s Oval Office announcement. Oz SPRUNG into action and assisted him. Pray for him.”

Viewers responded with prayers for the man's recovery as the live feed was abruptly cut.

Clarification on the Man’s Identity

The man was initially reported to be Gordon Findlay, alleged to be a Novo Nordisk executive, with some posts stating,

“BREAKING: Novo Nordisk executive Gordon Findlay collapses during Trump's announcement in Oval Office, announcement suspended.”

However, Novo Nordisk issued a statement clarifying the situation:

“CEO Mike Doustdar and EVP, US Operations, Dave Moore were the only two Novo Nordisk representatives in the Oval Office. We hope the gentleman who suffered a medical incident today is okay.”

White House Statement

White House Press Secretary Karoline Leavitt elaborated on the event:

“During the Most Favored Nations Oval Office Announcement, a representative with one of the companies fainted.”

Summary

The sudden fainting of a company representative during a high-profile Oval Office event sparked concern and false reports, but Novo Nordisk confirmed no executive of theirs was involved.

Author’s note: Initial confusion about the man’s identity was promptly corrected, highlighting the need for careful verification during breaking news events.

more

Hindustan Times Hindustan Times — 2025-11-06